Demystifying the ROI of Clinical AI
Demystifying the ROI of Clinical AI
Related Articles
NSF reexamines existing awards to comply with Trump’s directives
Normal operations have been disrupted as staff look for offending words
Anti-icing properties of polar bear fur
Polar bears are able to minimize ice accumulation thanks to their hair oil.
Tally of bones, artifacts reveals 2000 years of population swings among Indigenous Americans
Tens of thousands of radiocarbon dates track different regions’ population history before European arrival
New US sweat sensors track health in real-time with printed ink
Caltech just manufactured a wearable sweat sensor that “inkjet prints” biomarkers to better monitor the human body.
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Nature Biotechnology – An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Nature Biotechnology – An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
HHMI kills program aimed at boosting inclusivity in STEM education
“Inclusive excellence” program had committed $60 million to 104 institutions
EU issues guidelines on banned AI practices
The EU guidelines highlight prohibitions on harmful manipulation, real-time biometric identification and social scoring.
The fight against cholera is far from over. This Bangladeshi scientist is at the front lines
Firdausi Qadri hopes widespread use of cheap oral cholera vaccines can help vanquish an old scourge
Best in KLAS 2025 sees industry progress and vendor momentum
Despite staffing shortages and chaotic work environments, market researchers said increased clinician EHR satisfaction, improved payer/provider relationships and progress on SDOH are advancing